Literature DB >> 16366603

Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in Vivo.

Katrina M Miranda1, Tatsuo Katori, Claudia L Torres de Holding, Lynta Thomas, Lisa A Ridnour, William J McLendon, Stephanie M Cologna, Andrew S Dutton, Hunter C Champion, Daniele Mancardi, Carlo G Tocchetti, Joseph E Saavedra, Larry K Keefer, K N Houk, Jon M Fukuto, David A Kass, Nazareno Paolocci, David A Wink.   

Abstract

Diazeniumdiolates, more commonly referred to as NONOates, have been extremely useful in the investigation of the biological effects of nitric oxide (NO) and related nitrogen oxides. The NONOate Angeli's salt (Na(2)N(2)O(3)) releases nitroxyl (HNO) under physiological conditions and exhibits unique cardiovascular features (i.e., positive inotropy/lusitropy) that may have relevance for pharmacological treatment of heart failure. In the search for new, organic-based compounds that release HNO, we examined isopropylamine NONOate (IPA/NO; Na[(CH(3))(2)CHNH(N(O)NO]), which is an adduct of NO and a primary amine. The chemical and pharmacological properties of IPA/NO were compared to those of Angeli's salt and a NO-producing NONOate, DEA/NO (Na[Et(2)NN(O)NO]), which is a secondary amine adduct. Under physiological conditions IPA/NO exhibited all the markers of HNO production (e.g., reductive nitrosylation, thiol reactivity, positive inotropy). These data suggest that primary amine NONOates may be useful as HNO donors in complement to the existing series of secondary amine NONOates, which are well-characterized NO donors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16366603     DOI: 10.1021/jm050151i

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  50 in total

1.  A system for exposing molecules and cells to biologically relevant and accurately controlled steady-state concentrations of nitric oxide and oxygen.

Authors:  Vasileios Dendroulakis; Brandon S Russell; C Eric Elmquist; Laura J Trudel; Gerald N Wogan; William M Deen; Peter C Dedon
Journal:  Nitric Oxide       Date:  2012-06-21       Impact factor: 4.427

Review 2.  Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways.

Authors:  Robert Y S Cheng; Debashree Basudhar; Lisa A Ridnour; Julie L Heinecke; Aparna H Kesarwala; Sharon Glynn; Christopher H Switzer; Stefan Ambs; Katrina M Miranda; David A Wink
Journal:  Nitric Oxide       Date:  2014-08-19       Impact factor: 4.427

Review 3.  The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.

Authors:  Nazareno Paolocci; Matthew I Jackson; Brenda E Lopez; Katrina Miranda; Carlo G Tocchetti; David A Wink; Adrian J Hobbs; Jon M Fukuto
Journal:  Pharmacol Ther       Date:  2006-11-29       Impact factor: 12.310

Review 4.  The emergence of nitroxyl (HNO) as a pharmacological agent.

Authors:  Christopher H Switzer; Wilmarie Flores-Santana; Daniele Mancardi; Sonia Donzelli; Debashree Basudhar; Lisa A Ridnour; Katrina M Miranda; Jon M Fukuto; Nazareno Paolocci; David A Wink
Journal:  Biochim Biophys Acta       Date:  2009-05-06

5.  The shy Angeli and his elusive creature: the HNO route to vasodilation.

Authors:  Nazareno Paolocci; David A Wink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

6.  Enzymatic generation of the NO/HNO-releasing IPA/NO anion at controlled rates in physiological media using β-galactosidase.

Authors:  Ryan J Holland; Rika Paulisch; Zhao Cao; Larry K Keefer; Joseph E Saavedra; Sonia Donzelli
Journal:  Nitric Oxide       Date:  2013-10-11       Impact factor: 4.427

7.  Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.

Authors:  Guangshuo Zhu; Dieter Groneberg; Gautam Sikka; Daijiro Hori; Mark J Ranek; Taishi Nakamura; Eiki Takimoto; Nazareno Paolocci; Dan E Berkowitz; Andreas Friebe; David A Kass
Journal:  Hypertension       Date:  2014-12-01       Impact factor: 10.190

Review 8.  Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.

Authors:  Barbara K Kemp-Harper; John D Horowitz; Rebecca H Ritchie
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

9.  Dual mechanisms of HNO generation by a nitroxyl prodrug of the diazeniumdiolate (NONOate) class.

Authors:  Daniela Andrei; Debra J Salmon; Sonia Donzelli; Azadeh Wahab; John R Klose; Michael L Citro; Joseph E Saavedra; David A Wink; Katrina M Miranda; Larry K Keefer
Journal:  J Am Chem Soc       Date:  2010-10-29       Impact factor: 15.419

10.  The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols.

Authors:  Thomas W Miller; Melisa M Cherney; Andrea J Lee; Nestor E Francoleon; Patrick J Farmer; S Bruce King; Adrian J Hobbs; Katrina M Miranda; Judith N Burstyn; Jon M Fukuto
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.